Europe PMC
open access
Higher semaglutide dose is associated with lower neuropsychiatric event incidence independent of weight loss
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Weight Loss in Veterans with Schizophrenia and Multimorbidity Prescribed Semaglutide: Results From a National Retrospective Cohort Study.#461557
- A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range#894938
- Hunger pain and its reduction; qualitative insight from people with schizophrenia on semaglutide#676385
- Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight#981367
- A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity#872276
Record · ID 684656
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive